These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8328794)

  • 1. Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa.
    Zhou XY; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1387-9. PubMed ID: 8328794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
    Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
    Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
    J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase.
    Ho SE; Subramaniam G; Palasubramaniam S; Navaratnam P
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3286-7. PubMed ID: 12234862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Antimicrob Chemother; 1996 Aug; 38(2):287-91. PubMed ID: 8877544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Antimicrob Agents Chemother; 1995 Mar; 39(3):731-4. PubMed ID: 7793881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
    Gotoh N; Nishino T
    J Antimicrob Chemother; 1990 Feb; 25(2):191-8. PubMed ID: 2109748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
    Hazumi N; Kato Y; Hashizume T; Matsuda K
    J Antibiot (Tokyo); 1995 Nov; 48(11):1364-7. PubMed ID: 8557585
    [No Abstract]   [Full Text] [Related]  

  • 12. Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
    Tausk F; Evans ME; Patterson LS; Federspiel CF; Stratton CW
    Antimicrob Agents Chemother; 1985 Jul; 28(1):41-5. PubMed ID: 3929679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases.
    Livermore DM; Chen HY
    J Antimicrob Chemother; 1997 Sep; 40(3):335-43. PubMed ID: 9338484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems.
    Pournaras S; Ikonomidis A; Markogiannakis A; Spanakis N; Maniatis AN; Tsakris A
    J Med Microbiol; 2007 Jan; 56(Pt 1):66-70. PubMed ID: 17172519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-Nonsusceptible
    Asempa TE; Nicolau DP; Kuti JL
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31118271
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients.
    Ballestero S; Fernández-Rodríguez A; Villaverde R; Escobar H; Pérez-Díaz JC; Baquero F
    J Antimicrob Chemother; 1996 Jul; 38(1):39-45. PubMed ID: 8858455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.
    Dib C; Trias J; Jarlier V
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.
    Rodríguez-Martínez JM; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2009 May; 53(5):1766-71. PubMed ID: 19258272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.